N-(2-{4-[6-(4-methylphenyl)pyridazin-3-yl]-1,4-diazepan-1-yl}-2-oxoethyl)-N-[2-(morpholin-4-yl)ethyl]-2H-1,3-benzodioxole-5-carboxamide
Chemical Structure Depiction of
N-(2-{4-[6-(4-methylphenyl)pyridazin-3-yl]-1,4-diazepan-1-yl}-2-oxoethyl)-N-[2-(morpholin-4-yl)ethyl]-2H-1,3-benzodioxole-5-carboxamide
N-(2-{4-[6-(4-methylphenyl)pyridazin-3-yl]-1,4-diazepan-1-yl}-2-oxoethyl)-N-[2-(morpholin-4-yl)ethyl]-2H-1,3-benzodioxole-5-carboxamide
Compound characteristics
| Compound ID: | V028-0585 |
| Compound Name: | N-(2-{4-[6-(4-methylphenyl)pyridazin-3-yl]-1,4-diazepan-1-yl}-2-oxoethyl)-N-[2-(morpholin-4-yl)ethyl]-2H-1,3-benzodioxole-5-carboxamide |
| Molecular Weight: | 586.69 |
| Molecular Formula: | C32 H38 N6 O5 |
| Salt: | not_available |
| Smiles: | Cc1ccc(cc1)c1ccc(nn1)N1CCCN(CC1)C(CN(CCN1CCOCC1)C(c1ccc2c(c1)OCO2)=O)=O |
| Stereo: | ACHIRAL |
| logP: | 2.7787 |
| logD: | 2.7455 |
| logSw: | -2.9434 |
| Hydrogen bond acceptors count: | 10 |
| Polar surface area: | 86.081 |
| InChI Key: | OKZFEYHQIYASKJ-UHFFFAOYSA-N |